{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:30:48Z","timestamp":1782567048271,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,4]]},"DOI":"10.7759\/cureus.33339","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:28:45Z","timestamp":1672824525000},"source":"Crossref","is-referenced-by-count":2,"title":["A Comparative Study of Sublingual Misoprostol Versus Intramuscular Oxytocin in the Active Management of Third Stage of Labor"],"prefix":"10.7759","author":[{"given":"Shweta","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Tirkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupa","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. (2012). Accessed. October 2, 2022: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/75411\/9789241548502_eng.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S51661","article-title":"Prevention of postpartum hemorrhage in low-resource settings: current perspectives","volume":"5","author":"Prata N","year":"2013","unstructured":"Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health. 2013, 5:737-52. 10.2147\/IJWH.S51661","journal-title":"Int J Womens Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62171-6","article-title":"Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study","volume":"382","author":"Atukunda EC","year":"2013","unstructured":"Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. Lancet. 2013, 382:10. 10.1016\/S0140-6736(13)62171-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.100666","article-title":"Management of third stage of labor with misoprostol: a comparison of three routes of administration","volume":"3","author":"Bajwa SK","year":"2012","unstructured":"Bajwa SK, Bajwa SJ, Kaur H, Goraya SP, Singh A, Kaurishar H. Management of third stage of labor with misoprostol: a comparison of three routes of administration. Perspect Clin Res. 2012, 3:102-8. 10.4103\/2229-3485.100666","journal-title":"Perspect Clin Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.02.011","article-title":"New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop","volume":"85 Suppl 1","author":"Tsu VD","year":"2004","unstructured":"Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynaecol Obstet. 2004, 85 Suppl 1:S83-93. 10.1016\/j.ijgo.2004.02.011","journal-title":"Int J Gynaecol Obstet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000494.pub4","article-title":"Prostaglandins for preventing postpartum haemorrhage","volume":"2012","author":"Tun\u00e7alp \u00d6","year":"2012","unstructured":"Tun\u00e7alp \u00d6, Hofmeyr GJ, G\u00fclmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012, 2012:CD000494. 10.1002\/14651858.CD000494.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy","volume":"344","author":"Goldberg AB","year":"2001","unstructured":"Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001, 344:38-47. 10.1056\/NEJM200101043440107","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-012-0330-x","article-title":"Role of misoprostol 600 mcg oral in active management of third stage of labor: a comparative study with oxytocin 10 IU i.m","volume":"63","author":"Mukta M","year":"2013","unstructured":"Mukta M, Sahay PB. Role of misoprostol 600 mcg oral in active management of third stage of labor: a comparative study with oxytocin 10 IU i.m. J Obstet Gynaecol India. 2013, 63:325-7. 10.1007\/s13224-012-0330-x","journal-title":"J Obstet Gynaecol India"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10006-1098","article-title":"Sublingual misoprostol versus intramuscular oxytocin in the active management of third stage of labor","volume":"2","author":"Singhal SR","year":"2010","unstructured":"Singhal SR, Gupta N, Kunika, Nanda S. Sublingual misoprostol versus intramuscular oxytocin in the active management of third stage of labor. J South Asian Fed Obstet Gynecol. 2010, 2:199-202. 10.5005\/jp-journals-10006-1098","journal-title":"J South Asian Fed Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21608\/amj.2021.139729","article-title":"Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour","volume":"50","author":"Abd Elaty Abd Allah W","year":"2021","unstructured":"Abd Elaty Abd Allah W, Ibrahem Hassan F, Fawzy Mohamed M. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour. Al Azhar Med J. 2021, 50:367-76. 10.21608\/amj.2021.139729","journal-title":"Al Azhar Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001752","article-title":"Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial","volume":"11","author":"Atukunda EC","year":"2014","unstructured":"Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial. PLoS Med. 2014, 11:e1001752. 10.1371\/journal.pmed.1001752","journal-title":"PLoS Med"},{"key":"ref12","article-title":"Oral misoprostol versus oxytocin in the management of third stage of labour","volume":"64","author":"Aziz S","year":"2014","unstructured":"Aziz S, Kazi S, Haq G. Oral misoprostol versus oxytocin in the management of third stage of labour. J Pak Med Assoc. 2014, 64:428-32.","journal-title":"J Pak Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3126\/NJOG.V10I1.13203","article-title":"Comparison of oral misoprostol with intramuscular oxytocin in the active management of third stage of labour","volume":"19","author":"Kaudel S","year":"2015","unstructured":"Kaudel S, Rana A, Ojha N. Comparison of oral misoprostol with intramuscular oxytocin in the active management of third stage of labour. NJOG. 2015, 19:76-80. 10.3126\/NJOG.V10I1.13203","journal-title":"NJOG"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.IJRCOG20170373","article-title":"Active management of third stage of labour with low doses of oral misoprostol and oxytocin on low: risk parturient in a Sub-Saharan hospital, Dakar, S\u00e9n\u00e9gal","volume":"6","author":"Diallo M","year":"2017","unstructured":"Diallo M, Sylla T, Diouf AA, et al.. Active management of third stage of labour with low doses of oral misoprostol and oxytocin on low: risk parturient in a Sub-Saharan hospital, Dakar, S\u00e9n\u00e9gal. Int J Reprod Contracept Obstet Gynecol. 2017, 6:516-22. 10.18203\/2320-1770.IJRCOG20170373","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/TJOG.TJOG_16_19","article-title":"Misoprostol versus oxytocin in preventing postpartum hemorrhage: a randomized controlled trial","volume":"36","author":"Owa OO","year":"2019","unstructured":"Owa OO, Lemadoro AS, Temenu BA, Ayeyemi JA, Loto OM. Misoprostol versus oxytocin in preventing postpartum hemorrhage: a randomized controlled trial. Trop J Obstet Gynaecol. 2019, 36:196-9. 10.4103\/TJOG.TJOG_16_19","journal-title":"Trop J Obstet Gynaecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103931","article-title":"Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: a randomised controlled trial","volume":"78","author":"Sringamwong W","year":"2022","unstructured":"Sringamwong W, Saokaew S, Mongkhon P. Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: a randomised controlled trial. Ann Med Surg (Lond). 2022, 78:103931. 10.1016\/j.amsu.2022.103931","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/117875-a-comparative-study-of-sublingual-misoprostol-versus-intramuscular-oxytocin-in-the-active-management-of-third-stage-of-labor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:51Z","timestamp":1707508071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/117875-a-comparative-study-of-sublingual-misoprostol-versus-intramuscular-oxytocin-in-the-active-management-of-third-stage-of-labor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.33339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}